Krzych Łukasz J, Nadziakiewicz Paweł, Kucewicz-Czech Ewa
Department of Anaesthesiology and Intensive Care, Silesian Centre for Heart Diseases, Zabrze, Poland.
Department of Acute Medicine, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, Katowice, Poland.
Kardiochir Torakochirurgia Pol. 2024 Jun;21(2):96-98. doi: 10.5114/kitp.2024.141146. Epub 2024 Jun 30.
Angiotensin II (AT) is a potent vasoconstrictor and hypertensive drug that is registered for the treatment of severe hypotension in vasoplegic shock. Growing experience with the use of AT in cardiac surgery allows the first therapeutic algorithms to be created. This paper is a proposal for the use of AT in distributive shock after extracorporeal circulation.
血管紧张素II(AT)是一种强效血管收缩剂和高血压药物,已注册用于治疗血管麻痹性休克中的严重低血压。在心脏手术中使用AT的经验不断积累,使得首个治疗方案得以制定。本文提出了在体外循环后分布性休克中使用AT的建议。